Evaluation of antipsychotic utilization among outpatient schizoprenia patients at the mental health facility in West Java
Abstract
Rational use of drugs aims to give therapy according to patient’s clinical needs. Based on Ni komang's research (2021) there are still inaccuracies in the use of antipsychotic drugs. The purpose of this study was to determine the evaluation of the use of Antipsychotics based on the parameters of right indications, drugs, dosage, and frequency in outpatient schizophrenia patients at the West Java Provincial Mental Hospital. The study used a method with descriptive presentation of data and retrospective data collection. Data obtained period October-December 2022 from 130 patients, this study evaluated the use of Antipsychotics with the parameters of right indications, drugs, dosage, and frequency then the data will be analyzed based on the criteria for drug use from Pharmacotherapy A Pathophysiologic Approach 11th and PIONAS. The results of the study on the use of Antipsychotics in schizophrenic patients at the Java Provincial Mental Hospital based on Pharmacotherapy A Pathophysiologic Approach 11th and PIONAS obtained the right indications as much as (100%), the right drugs (100%), the right dose (98%), and the right frequency (98%).
References
[2.] Kementerian Kesehatan Republik Indonesia, "Modul Penggunaan Obat Rasional," Jakarta, 2016.
[3.] H. Dania et al., "Hubungan Pemberian Terapi Antipsikotik terhadap Kejadian Efek Samping Sindrom Ekstrapiramidal pada Pasien Rawat Jalan di Salah Satu Rumah Sakit di Bantul, Yogyakarta," Indonesian Journal of Clinical Pharmacy, vol. 8, no. 1, 2019, doi: 10.15416/ijcp.2019.8.1.19.
[4.] J. T. DiPiro, G. C. Yee, L. M. Posey, S. T. Haines, T. D. Nolin, and V. Ellingrod, Pharmacotherapy: A Pathophysiologic Approach, 11th ed. 2020.
[5.] N. Khofifah, P. Mukti, and M. R. Adam, "Evaluasi Ketepatan Antipsikotik pada Pasien Skizofrenia di Instalasi Rawat Inap Rumah Sakit Jiwa Daerah Atma Husada Mahakam Samarinda," 2020.
[6.] D. Hawari, Skizofrenia Pendekatan Holistik (BPSS) Bio-Psiko-Sosial-Spiritual, 3rd ed. Jakarta: Badan Penerbit Fakultas Kedokteran Universitas Indonesia, 2014.
[7.] J. M. Khoirunnisa, H. Dania, and I. N. Faridah, "Hubungan Jumlah Obat dengan Potensial Kejadian Interaksi Obat pada Pasien Skizofrenia di Salah Satu Rumah Sakit di Kulon Progo, Yogyakarta," vol. 18, no. 02, pp. 267–291, 2021.
[8.] Fakultas Kedokteran Universitas Indonesia, Buku Ajar: Psikiatri. Jakarta: Departement Kedokteran Universitas Indonesia, 2010.
[9.] W. A. Maramis and A. A. Maramis, Catatan Ilmu Kedokteran Jiwa, 8th ed. Airlangga University Press, 2004.
[10.] A. Rahaya and N. Cahaya, "Study Of The Trihexyfenidil Use Inpatients Schizophrenia ' S Receiving Antipsychotic Therapy At Sambang Lihum Hospital South Borneo," vol. 2, pp. 124–131, 2020.
[11.] I. G. A. V. Swayami, "Aspek Biologi Triheksifenidil di Bidang Psikiatri," Program Pendidikan Dokter Spesialis-1 Psikiatri, Fakultas Kedokteran Universitas Udayana: Rumah Sakit Umum Pusat Sanglah Denpasar, 2014.
[12.] S. U. Hadayani, "Evaluasi penggunaan obat antipsikotik pada pasien skizofrenia di rawat inap rumah sakit jiwa daerah surakarta periode 2017," Fakultas Farmasi Universitas Setia Budi Surakarta, Surakarta, 2017.
[13.] T. H. Tjay and K. Rahardja, Obat-Obat Penting, 7th ed. 2015.
[14.] B. R. Sinaga, Skizofrenia dan Diagnosis Banding. Jakarta: Penerbit Fakultas Kedokteran Universitas Indonesia, 2007.
[15.] Fahrul, "Rasionalitas Penggunaan Antipsikotik pada Pasien Rawat Inap Rumah sakit Jiwa daerah Madani Provinsi Sulawesi Tengah Periode Januari-April 2014," Jurnal of Natural Science, vol. 3, pp. 18–29, 2014.
[16.] F. R. L. Maharani, "Kajian Penggunaan Obat Antipsikosis pada Pasien Skizofrenia di Unit Rawat Inap Rumah Sakit Grhasia Propinsi Daerah Istimewa Yogyakarta Periode Januari-Desember 2003," Fakultas Farmasi Universitas Sanata Dharma, Yogyakarta, 2004.
[17.] N. Amir, Buku Ajar Psikiatri: Skizofrenia. Jakarta: Badan Penerbit Fakultas Kedokteran Universitas Indonesia, 2013.

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.
This licence applies to Author(s) and Public Reader means that the users mays :
- SHARE:
copy and redistribute the article in any medium or format - ADAPT:
remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication) - ALIKE:
If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original. - NO ADDITIONAL RESTRICTIONS:
You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
It does however mean that when you use it you must:
- ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
You may not:
- NONCOMMERCIAL: You may not use the article for commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.